Despite its long demonstrated clinical efficacy in FMF patients, colchicine was recently shown to be inefficient in blocking IL‐1β release in PBMCs from FMF patients exposed to TcdA (Van Gorp et al, 2016). The gene discussed is IL1B; the disease is familial Mediterranean fever.